Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse γ-Hydroxybutyric Acid-Reference-Cited by-同舟云学术

Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse γ-Hydroxybutyric Acid

Published:2008-06 Issue:2 Volume:10 Page:
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Morris Marilyn E.,Felmlee Melanie A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1208/s12248-008-9035-6.pdf

Reference105 articles.

1. V. N. Jackson, and A. P. Halestrap. The kinetics, substrate, and inhibitor specificity of the monocarboxylate (lactate) transporter of rat liver cells determined using the fluorescent intracellular pH indicator, 2’,7’-bis(carboxyethyl)-5(6)-carboxyfluorescein. J. Biol. Chem. 271(2):861–868 (1996), Jan 12.

2. A. P. Halestrap, and N. T. Price. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343(Pt 2):281–299 (1999), Oct 15.

3. Y. Murakami, N. Kohyama, Y. Kobayashi, et al. Functional characterization of human monocarboxylate transporter 6 (SLC16A5). Drug Metab. Dispos. 33(12):1845–1851 (2005), Dec.

4. A. P. Halestrap, and D. Meredith. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 447(5):619–628 (2004), Feb.

5. I. Bhattacharya, and K. M. Boje. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier. J. Pharmacol. Exp. Ther. 311(1):92–98 (2004), Oct.

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monokarboksil Taşıyıcı Proteinler ve Egzersizdeki Rolü;CBÜ Beden Eğitimi ve Spor Bilimleri Dergisi;2024-07-31

2. Heterogeneous brain distribution of bumetanide following systemic administration in rats;Biopharmaceutics & Drug Disposition;2024-06

3. Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?;Pharmaceutics;2024-03-24

4. GHB toxicokinetics and renal monocarboxylate transporter expression are influenced by the estrus cycle in rats;BMC Pharmacology and Toxicology;2023-11-02

5. Expression and Pharmaceutical Relevance of Intestinal Transporters;Oral Bioavailability and Drug Delivery;2023-10-10